Gastrointestinal Signet Ring Cell Malignancy: Current Advancement and Future Prospects

Weiping Hong,Qingjun Hu,Yuan Tan,Qianqian Duan,Qin Zhang,Dongsheng Chen,Chuang Qi,Da Wang
DOI: https://doi.org/10.1007/s10637-023-01403-1
2023-01-01
Investigational New Drugs
Abstract:Globally, gastrointestinal cancer is the most widespread neoplastic disease and the primary contributor to cancer-associated fatalities. Gastrointestinal signet ring cell carcinoma (SRCC) exhibits unique distinguishing features in several aspects when compared to adenocarcinomas (ACs). The scarcity of signet ring cell carcinoma has resulted in a heightened significance of related clinical and molecular investigations. However, a comprehensive and systematic review of the clinical, molecular, therapeutic, and research aspects of this disease is currently absent. This review provides an overview of the latest developments in our understanding of the clinical and molecular features of gastrointestinal signet ring cell carcinoma (SRCC). Additionally, we have compiled a list of potential therapeutic targets or biomarkers, as well as an examination of the current treatment options and the possible mechanisms of formation.
What problem does this paper attempt to address?